Neoplasms: all 9,616 studies

Page 30 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)CompletedNCT03220035Phase 2Results posted
• A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerCompletedNCT03219333Phase 2Results posted
• Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)CompletedNCT03213691Phase 2Results posted
• Neuromuscular Blockade on Shoulder Pain of ElderlyCompletedNCT03210376Phase 4Results posted
• A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)CompletedNCT03207347Phase 2Results posted
• Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral BodyCompletedNCT03204942Not applicableResults posted
• Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT03204812Phase 2Results posted
• Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial NeoplasiaCompletedNCT03196180Early Phase 1Results posted
• A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive CancerCompletedNCT03194893Phase 3Results posted
• Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic NeoplasmsCompletedNCT03188991Phase 2Results posted
• Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to EngraftTerminatedNCT03187756Phase 2Results posted
• Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With CancerCompletedNCT03186638Phase 2Results posted
• Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)CompletedNCT03179436Phase 1/2Results posted
• A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have SpreadTerminatedNCT03166631Phase 1Results posted
• A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has SpreadCompletedNCT03158272Phase 1Results posted
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
• This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.CompletedNCT03156114Phase 1Results posted
• Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid TumorsCompletedNCT03154294Phase 1Results posted
• Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT03150810Phase 1Results posted
• Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)CompletedNCT03140280Phase 2Results posted
• Investigation of Sugammadex in Outpatient Urological ProceduresCompletedNCT03138967Phase 4Results posted
• Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer PatientsCompletedNCT03137121Phase 2/3Results posted
• Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese AdultsTerminatedNCT03135028Phase 1Results posted
• A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) MalignanciesCompletedNCT03130959Phase 2Results posted
• Expanding Access to Home-Based Palliative CareTerminatedNCT03128060Not applicableResults posted
• HUMC 1612: Optune NovoTTF-200A SystemCompletedNCT03128047Phase 1Results posted
• CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With NivolumabCompletedNCT03123783Phase 1/2Results posted
• Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or OxaliplatinCompletedNCT03122886Not applicableResults posted
• Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare TumorsCompletedNCT03108131Phase 2Results posted
• This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerCompletedNCT03099174Phase 1Results posted
• Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)TerminatedNCT03099161Phase 1Results posted
• Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell TransplantCompletedNCT03097588Phase 2Results posted
• Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung OriginCompletedNCT03095274Phase 2Results posted
• A Study of AK-01 (LY3295668) in Solid TumorsCompletedNCT03092934Phase 1/2Results posted
• APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT03087591Phase 1Results posted
• A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)CompletedNCT03085914Phase 1/2Results posted
• An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.CompletedNCT03084471Phase 3Results posted
• An Innovative Treatment for Cervical Precancer (UH3)CompletedNCT03084081Not applicableResults posted
• Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic MalignanciesCompletedNCT03082677Phase 2Results posted
• Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation TherapyCompletedNCT03080883Phase 3Results posted
• A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid TumorsCompletedNCT03077607Phase 1Results posted
• P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCCCompletedNCT03077243Phase 2Results posted
• A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative NeoplasmsCompletedNCT03075826Phase 2Results posted
• Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base SurgeryCompletedNCT03072186Not applicableResults posted
• Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid NeoplasmsCompletedNCT03072043Phase 1/2Results posted
• A Study of Talazoparib in Patients With Advanced Solid TumorsCompletedNCT03070548Phase 1Results posted
• Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck CancerCompletedNCT03067610Phase 2Results posted
• PD-1 Inhibition in Advanced Myeloproliferative NeoplasmsCompletedNCT03065400Phase 2Results posted
• Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & LymphomaCompletedNCT03061188Phase 1Results posted
• Stepped-Care Telehealth for Distress in Cancer SurvivorsCompletedNCT03060096Not applicableResults posted
• A Study of [14 C]-Pevonedistat in Participants With Advanced Solid TumorsCompletedNCT03057366Phase 1Results posted
• Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid MalignanciesCompletedNCT03056339Phase 1/2Results posted
• HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal LesionsTerminatedNCT03051516Phase 4Results posted
• SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03050554Phase 1/2Results posted
• A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid TumorsCompletedNCT03042910Phase 1Results posted
• Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With CancerCompletedNCT03040726Phase 2/3Results posted
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
• Phase 2 Study of ONC201 in Neuroendocrine TumorsCompletedNCT03034200Phase 2Results posted
• QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid TumorsCompletedNCT03027128Phase 1Results posted
• Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid NeoplasmCompletedNCT03012672Phase 2Results posted
• Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid TumorsCompletedNCT03006887Phase 1Results posted
• Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge NeedleCompletedNCT03004586Not applicableResults posted
• Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme MalignanciesTerminatedNCT02991898Phase 2Results posted
• Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCTCompletedNCT02988466Phase 2Results posted
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)TerminatedNCT02978716Phase 2Results posted
• Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsCompletedNCT02975882Phase 1Results posted
• Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device PerformanceCompletedNCT02974842Results posted
• Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)TerminatedNCT02972034Phase 1Results posted
• Engagement of Patients With Advanced CancerCompletedNCT02966509Not applicableResults posted
• Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerTerminatedNCT02964507Phase 1Results posted
• Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative ThrombocytopeniaTerminatedNCT02964325Not applicableResults posted
• Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)CompletedNCT02964013Phase 1Results posted
• RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous NeoplasiaTerminatedNCT02953418Not applicableResults posted
• A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid TumoursCompletedNCT02952248Phase 1Results posted
• Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic TherapyTerminatedNCT02949947Phase 2Results posted
• Household Air Pollution and Health: A Multi-country LPG Intervention TrialCompletedNCT02944682Not applicableResults posted
• Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced CancerTerminatedNCT02940223Phase 2Results posted
• First in Human Study of IBI308 in Chinese Subjects With Advanced Solid TumorsCompletedNCT02937116Phase 1Results posted
• A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic CancersCompletedNCT02919696Phase 1Results posted
• ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive TreatmentTerminatedNCT02917629Phase 2Results posted
• A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid TumorsCompletedNCT02913313Phase 1/2Results posted
• Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor MalignanciesTerminatedNCT02913131Phase 1/2Results posted
• Sym013 (Pan-HER) in Patients With Advanced Epithelial MalignanciesTerminatedNCT02906670Phase 1/2Results posted
• Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.CompletedNCT02903771Phase 1Results posted
• Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerCompletedNCT02898207Phase 1Results posted
• Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by SurgeryCompletedNCT02893930Phase 2Results posted
• Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant TreatmentCompletedNCT02891681Not applicableResults posted
• A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid TumorsTerminatedNCT02880371Phase 1/2Results posted
• French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic DocumentationCompletedNCT02874001Results posted
• A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid TumorsCompletedNCT02869295Phase 1/2Results posted
• Information Consultation by Radiotherapy ManipulatorCompletedNCT02867462Not applicableResults posted
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)Active, not recruitingNCT02864992Phase 2Results posted
• Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation ExposureTerminatedNCT02864316Phase 2Results posted
• Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961CompletedNCT02860676Phase 1Results posted
• High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell TransplantCompletedNCT02860039Phase 2Results posted
• Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary MetastasesTerminatedNCT02859415Phase 1/2Results posted
• Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 MicrospheresTerminatedNCT02859064Phase 2Results posted
• Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III MelanomaActive, not recruitingNCT02858921Phase 2Results posted
• Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing SurgeryTerminatedNCT02855086Phase 1/2Results posted
• Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction CancerCompletedNCT02830594Phase 2Results posted

← Neoplasms overview